换一批
换一批Progestin and antiprogestin responsiveness in breast cancer is driven by the PRA/PRB ratio via AIB1 or SMRT recruitment to the CCND1 and MYC promoters.
作者：
主题词
动物(Animals);细胞系, 肿瘤(Cell Line, Tumor);细胞增殖(Cell Proliferation);细胞周期蛋白D1(Cyclin D1);女(雌)性(Female);人类(Humans);乳房肿瘤, 实验性(Mammary Neoplasms, Experimental);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 裸(Mice, Nude);米非司酮(Mifepristone);核受体共阻遏蛋白2(Nuclear Receptor Co-Repressor 2);核受体共激活因子3(Nuclear Receptor Coactivator 3);孕激素类(Progestins);启动区, 遗传(Promoter Regions, Genetic);原癌基因蛋白质c-myc(Proto-Oncogene Proteins c-myc);受体, 孕酮(Receptors, Progesterone)
DOI
10.1002/ijc.29304
PMID
25363551
发布时间
2019-10-08
- 浏览56
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
